About NetScientific

NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.

NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.

NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.

An entrepreneur-led senior management team with extensive biomedical, healthcare and commercial experience.

  • Sir Richard Sykes FRS

  • François Martelet M.D.

  • Vijay Barathan M.D.

Our Portfolio

  • Digital Health
  • Diagnostics
  • Therapeutics

Unique Partnership Model

The partnership with Breakout Labs provides NetScientific and its investors with access to some of the most revolutionary new technologies coming out of Silicon Valley and beyond.


Latest News

RNS Announcements

  • 09-02-2016 – PDS Biotechnology partners with NCI >>
  • 08-02-2016 – Grant of Options to Director >>
  • 26-01-2016 – Directorate Change >>
  • 20-01-2016 – PDS Biotechnology adds drug development executives >>
  • 06-01-2016 – Glycotest Inc. appoints medical advisory board >>
  • 04-01-2016 – WANDA signs contract with HRS >>

NetScientific Portfolio News

News from Vortex BioSciences

  • Meet Vortex at SLAS 2016 – January 23-27, 2016 in San Diego, USA

    2016-01-18 07:41

  • High efficiency vortex trapping of circulating tumor cells

    2015-12-29 07:19

  • Meet our collaborators at MicroTAS 2015 – October 25-29, 2015 in Gyeongju, KOREA

    2015-10-09 03:59


News from ProAxsis

  • ProAxsis CEO to present at Biotech and Money conference

    2016-01-28 04:52

  • Renowned protease expert confirmed as CSO of ProAxsis

    2016-01-20 01:05

  • ProAxsis collaboration highlighted as success story by the Medical Research Council

    2015-12-09 12:02

News from Glycotest

  • NetScientific portfolio company, Glycotest Inc., appoints world leading medical advisory board chaired by David Chernoff, M.D.

    2016-01-06 03:12

  • NetScientific appoints diagnostics leader Lawrence Cohen as CEO of Glycotest Inc.

    2015-12-16 02:23

  • NetScientific’s subsidiary, Glycotest Begins a New Research Collaboration with Oncimmune

    2014-10-03 11:14